FLUDOT 0.5 MG INJECTION
| Brand Name | Fludot |
| Dosage Form | Injection |
| Strength | 0.5 mg |
| Active Ingredient | Fludarabine |
| Therapeutic Class | Anticancer / Chemotherapy Drug |
| Indication | Chronic lymphocytic leukemia and non-Hodgkin lymphoma |
| Route of Administration | Intravenous infusion |
| Prescription | Required |
| Storage | Store in refrigerator, protect from light |
| Packaging | Vial |
FLUDOT 0.5 MG INJECTION
Fludot 0.5 mg Injection is an effective anticancer medication containing Fludarabine, a chemotherapy drug used in the treatment of certain blood cancers such as chronic lymphocytic leukemia (CLL) and low-grade non-Hodgkin lymphoma. This pharmaceutical product works by interfering with cancer cell growth and preventing their multiplication, helping slow disease progression under specialist medical care.
Fludot Injection is administered intravenously by healthcare professionals to ensure accurate dosing and safe monitoring. It targets abnormal cancer cells while supporting better disease control when used as part of a chemotherapy regimen. The medicine is widely used in oncology treatment plans due to its proven effectiveness in managing hematologic malignancies.
Fludot 0.5 mg Injection plays a vital role in improving treatment outcomes and enhancing patient care. With proper medical supervision, it helps control cancer progression, improve symptoms, and support overall treatment success in patients undergoing chemotherapy for blood-related cancers.
Product Features
- Contains Fludarabine β an effective anticancer agent
- Used in treatment of leukemia and lymphoma
- Intravenous chemotherapy formulation
- Clinically proven oncology medication
- Administered under specialist supervision
How It Helps
- Slows growth of cancer cells
- Helps manage chronic lymphocytic leukemia
- Supports treatment of low-grade lymphoma
- Improves overall cancer treatment outcomes

Reviews
There are no reviews yet.